Axel Maximilian Hillmer

21PUBLICATIONS
134CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Biogeography and phylogeographyPredictive and prognostic markersMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 08, 2026
FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC.

|Nov 11, 2024
Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score.

Christoph Arolt, Andreas H Scheel, Margaret Dugan

|Oct 26, 2022
Common Germline Risk Variants Impact Somatic Alterations and Clinical Features across Cancers.

Shinichi Namba, Yuki Saito, Yasunori Kogure

Pageof 4